Philips Introduces First Commercial MR-only Solution for Prostate Cancer Treatment Planning in U.S.

By: via Benzinga
Royal Philips (NYSE: PHG) today introduced the first commercially available MR-only simulation solution indicated for prostate cancer ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.